Resting and Dynamic Brain Glutamate by MRS In Vivo: Relation to Suicidal Behavior (Depressed Patients with a Recent Suicide Attempt)
| Sponsor: |
National Institute of Mental Health |
| Enrolling: |
Male and Female Patients |
| Study Length: |
1 Months |
| Clinic Visits: |
3 |
| IRB Number: |
AAAV4037 |
| Contact: |
Camila Gomez Restrepo: 929-646-8598 / herzoglab@cumc.columbia.edu |
HAVE YOU HAD A SUICIDE ATTEMPT WITHIN THE LAST 5 YEARS? We are conducting a study on depression and suicide risk, and participants can earn up to $300. Suicide rates in the U.S. are rising, and new treatments are urgently needed. This study focuses on glutamate, a brain chemical that may play an important role in mood and mental health. We will compare glutamate levels in people with depression with and without a history of suicide attempts and in healthy volunteers. We are looking for people with depression who have had a suicide attempt within the last 5 years. Please email herzoglab@cumc.columbia.edu for more information.
Investigator
Sarah Herzog, PhD
| Have you had ketamine in any form in the last 3 months? |
Yes |
No |
| Are you currently pregnant, breastfeeding, or trying to become pregnant? |
Yes |
No |
| Do you have a parent, child, or sibling with a history of schizophrenia? |
Yes |
No |
| Do you have conditions requiring daily use of stimulants, anxiety or sleep medications, antihistamines, or NSAIDs? |
Yes |
No |
| Have you had a suicide attempt within the last 5 years? |
Yes |
No |